Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arovella Therapeutics Ltd
Operating Expenses Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Operating Expenses
-AU$8.9m
CAGR 3-Years
-24%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Operating Expenses
-AU$381.1m
CAGR 3-Years
-33%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Operating Expenses
-AU$38.2m
CAGR 3-Years
-48%
CAGR 5-Years
-27%
CAGR 10-Years
-13%
Botanix Pharmaceuticals Ltd
ASX:BOT
Operating Expenses
-AU$12.8m
CAGR 3-Years
-7%
CAGR 5-Years
10%
CAGR 10-Years
-37%
Probiotec Ltd
ASX:PBP
Operating Expenses
-AU$46.2m
CAGR 3-Years
-27%
CAGR 5-Years
-18%
CAGR 10-Years
-7%
Vita Life Sciences Ltd
ASX:VLS
Operating Expenses
-AU$33.9m
CAGR 3-Years
-15%
CAGR 5-Years
-7%
CAGR 10-Years
-6%

See Also

What is Arovella Therapeutics Ltd's Operating Expenses?
Operating Expenses
-8.9m AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Operating Expenses amounts to -8.9m AUD.

What is Arovella Therapeutics Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-21%

Over the last year, the Operating Expenses growth was 10%. The average annual Operating Expenses growth rates for Arovella Therapeutics Ltd have been -24% over the past three years , -21% over the past five years .

Back to Top